Bang·Er Orthopedic Secures ￥300 Million in Series D Funding

(VCBeat) Jan. 19, 2021 -- Recently, Zhejiang Boner Medical Investment Management Co., Ltd. ("Bang·Er Orthopedic") announced closing a Series D round of 300 million RMB with participation from Fortune Venture Capital and Cenova Capital.

Since 2014, Bang·Er Orthopedic has raised three rounds of financing from investors including Eight Roads, GP Capital and Qiming Venture Partners, which have promoting the rapid development of the company. At present, Bang·Er Orthopedic owns and operates 14 chain hospitals. By the end of 2020, it has developed into a large specialized hospital management group with a total capacity of more than 4,000 open beds and an annual operation volume of nearly 30,000.

Cheng Dong, founder and chairman of Bang·Er Orthopedic, said that after three rounds of financing, Banger has developed rapidly to become a private orthopedic hospital group with a large scale, strong strength, and good reputation in China. Headquartered in Zhejiang Province, the group has expanded its business across the country. the successful D round financing will enable Bang·Er Orthopedic to realize the vision to "take the nature of medicine as the core, bring the leading technology and high-quality service of orthopedics to the public, and become a global brand of orthopedic hospitals".

Founded in April 2000, Fortune Capital is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focuses its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture, and Clean Tech.

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 and is one of the earliest investors in private healthcare services and digital health. Currently, Cenova Capital has five funds under management and invested in over 50 companies with a proven track record across three funds.